SEC 13F Intelligence

Versant Venture Management, LLC / BOLDEUR

Versant Venture Management, LLC’s Audentes Therapeutics Inc Position

Does Versant Venture Management, LLC own Audentes Therapeutics Inc (BOLDEUR)? Not currently — the last reported position was 553.9K shares worth $15.6B in Q3 2019; the fund’s latest 13F (Q1 2026) no longer reports it.

Position Value
$15.6B
Q3 2019
Shares
553.9K
% of Portfolio
+6.02%
Quarters Held
4
position exited

Position History BOLDEUR

Reported value by quarter
Q4 ’18: $25.7BQ4 ’18Q1 ’19: $31.3BQ1 ’19Q2 ’19: $21.0BQ2 ’19Q3 ’19: $15.6BQ3 ’19filingsflow.com
QuarterSharesValue% of Portfolio
Q3 2019553.9K$15.6B+6.02%
Q2 2019553.9K$21.0B+6.11%
Q1 2019803.1K$31.3B+10.32%
Q4 20181.20M$25.7B+12.71%

Common-stock position only; options are excluded. Quarters where the fund filed no 13F or reported no position are absent. See Versant Venture Management, LLC’s full portfolio or all institutional holders of BOLDEUR.